(Q31911220)

4 July 2017

title

Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. (English)

1 reference

4 July 2017

0 references

Zubieta JK

1

1 reference

4 July 2017

Koeppe RA

2

1 reference

4 July 2017

Frey KA

3

1 reference

4 July 2017

Kilbourn MR

4

1 reference

4 July 2017

Mangner TJ

5

1 reference

4 July 2017

Foster NL

6

1 reference

4 July 2017

Kuhl DE

7

1 reference

4 July 2017

publication date

1 March 2001

1 reference

4 July 2017

1 reference

4 July 2017

volume

39

1 reference

4 July 2017

issue

4

1 reference

4 July 2017

page(s)

275-287

1 reference

Strategy for the measurement of regional cerebral blood flow using short-lived tracers and emission tomography.

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Brain blood flow in the dementias: SPECT with histopathologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Cortical abnormalities in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

In vivo Muscarinic Cholingeric Receptor Imaging in Human Brain with [11C]Scopolamine and Positron Emission Tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Pathological and positron emission tomographic correlations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Cholinergic receptors in human brain: effects of aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Muscarinic receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Alzheimer's disease. Age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

[11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Decreases in regional cerebral blood flow with normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Regional cerebral blood flow and oxygen consumption in human aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Effect of chronic cholinergic denervation on the m1 muscarinic receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Kinetic analysis of 3-quinuclidinyl 4-[125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Presynaptic cholinergic dysfunction in patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

An acute effect of triazolam on muscarinic cholinergic receptor binding in the human brain measured by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Comparison of the level of mRNA encoding m1 and m2 muscarinic receptors in brains of young and aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Neocortical cholinergic neurons in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Stability of cerebral blood flow and oxygen metabolism during normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Aging and brain cholinergic muscarinic receptors: an autoradiographic study in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

External imaging of cerebral muscarinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

The cholinergic system in old age and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010315%2939%3A4%3C275%3A%3AAID-SYN1010%3E3.0.CO%3B2-3

10.1002/1098-2396(20010315)39:4<275::AID-SYN1010>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

4 July 2017

1 reference